Predictors of recurrence in high-grade cervical lesions and a plan of management

被引:59
作者
Leguevaque, P. [1 ]
Motton, S. [1 ]
Decharme, A. [1 ]
Soule-Tholy, M. [1 ]
Escourrou, G. [2 ]
Hoff, J. [1 ]
机构
[1] CHU Rangueil, Dept Gen & Gynecol Surg, F-31059 Toulouse 9, France
[2] CHU Rangueil, Dept Anatomopathol, F-31059 Toulouse 9, France
来源
EJSO | 2010年 / 36卷 / 11期
关键词
CIN II; CIN III; Dysplasia; HPV test; Recurrence; Persistence; Follow-up; LARGE-LOOP EXCISION; HUMAN-PAPILLOMAVIRUS INFECTION; HISTOLOGICAL INCOMPLETE EXCISION; INTRAEPITHELIAL NEOPLASIA; HIGH-RISK; TRANSFORMATION ZONE; ELECTROSURGICAL EXCISION; FOLLOW-UP; LASER VAPORIZATION; CONIZATION;
D O I
10.1016/j.ejso.2010.08.135
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Precis: Positive endocervical margins are an important predictor of recurrence in high-grade cervical lesions, and though they do not always warrant retreatment, closer surveillance is recommended. Objective: To identify predictors of recurrence and persistence of high-grade cervical dysplasia and to determine appropriate follow-up. Design: prospective pilot study. Setting: Gynaecological surgical center. Population: Three hundred fifty-two patients were treated between 1999 and 2002 for high-grade lesions. Methods: According to the accessibility of the transformation zone and the degree of dysplasia, patients were treated either by conization or by loop electrosurgical excision procedure (LEEP). Follow-up comprised colposcopy and Pap-smear screening 4-6 months after treatment as well as high-risk human papillomavirus (HR-HPV) testing before and after treatment. Main outcome measures: underscore predictors of recurrence and propose a treatment flowchart for both management and follow-up. Results: Of the 352 patients, 37 (10.5%) had true recurrence 6 months after initial surgical treatment and 6 patients (1.7%) had persistent lesions. Overall, 43 patients (12.2%) were considered as having recurrent disease. Patients were followed up for 5 years with a mean of 73 months. The most important predictor of recurrence was a positive HR-HPV test at 6 months postoperatively (odds ratio 38.8, 95% confidence interval 14.09, 107.05). The second significant predictor was positive endocervical margins and the third was positive pre-treatment HPV typing. A positive post-treatment HPV test had a more significant influence on risk than a positive test before treatment. Conclusion: In agreement with recent findings, our study supports the usefulness of the HR-HPV test in the follow-up of treated high-grade lesions, especially when excision margins were positive. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1073 / 1079
页数:7
相关论文
共 35 条
[1]   Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3 [J].
Alonso, Immaculada ;
Torne, Aureli ;
Puig-Tintore, Luis M. ;
Esteve, Roser ;
Quinto, Llorenc ;
Campo, Elias ;
Pahisa, Jaume ;
Ordi, Jaume .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :631-636
[2]  
Apgar BS, 2009, AM FAM PHYSICIAN, V80, P147
[3]   Clinical utility of HPV-DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence [J].
Arbyn, M ;
Paraskevaidis, E ;
Martin-Hirsch, P ;
Prendiville, W ;
Dillner, J .
GYNECOLOGIC ONCOLOGY, 2005, 99 (03) :S7-S11
[4]   Cytology and colposcopy after loop electrosurgical excision: Implications for follow-up [J].
Baldauf, JJ ;
Dreyfus, M ;
Ritter, J ;
Cuenin, C ;
Tissier, I ;
Meyer, P .
OBSTETRICS AND GYNECOLOGY, 1998, 92 (01) :124-130
[5]   Combined colposcopy, loop conization, and laser vaporization reduces recurrent abnormal cytology and residual disease in cervical dysplasia [J].
Bar-Am, A ;
Daniel, Y ;
Ron, IG ;
Niv, J ;
Kupferminc, MJ ;
Bornstein, J ;
Lessing, JB .
GYNECOLOGIC ONCOLOGY, 2000, 78 (01) :47-51
[6]   Clearance of cervical human papillomavirus infection by treatment for cervical dysplasia [J].
Bollen, LJM ;
TjongAHung, SP ;
VanderVelden, J ;
Mol, BW ;
Boer, K ;
TenKate, FJW ;
Bleker, OP ;
terSchegget, J .
SEXUALLY TRANSMITTED DISEASES, 1997, 24 (08) :456-460
[7]   Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology [J].
Bollen, LJM ;
Tjong-A-Hung, SP ;
van der Velden, J ;
Mol, BW ;
ten Kate, FWJ ;
ter Schegget, J ;
Bleker, OP .
GYNECOLOGIC ONCOLOGY, 1999, 72 (02) :199-201
[8]   Persistent and recurrent cervical dysplasia after loop etectrosurgical excision procedure [J].
Brockmeyer, AD ;
Wright, JD ;
Gao, F ;
Powell, MA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (05) :1379-1381
[9]   INVASIVE-CARCINOMA AFTER CONE BIOPSY FOR CERVICAL INTRAEPITHELIAL NEOPLASIA [J].
BROWN, JV ;
PETERS, WA ;
CORWIN, DJ .
GYNECOLOGIC ONCOLOGY, 1991, 40 (01) :25-28
[10]   Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review [J].
Chan, Benjamin K. S. ;
Melnikow, Joy ;
Slee, Christina A. ;
Arellanes, Rose ;
Sawaya, George F. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (04) :422.e1-422.e9